UG Stock Overview
Manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
United-Guardian, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$9.75 |
52 Week High | US$16.25 |
52 Week Low | US$6.75 |
Beta | 0.81 |
11 Month Change | -25.63% |
3 Month Change | -28.26% |
1 Year Change | 25.00% |
33 Year Change | -38.95% |
5 Year Change | -51.85% |
Change since IPO | 86.39% |
Recent News & Updates
United-Guardian, Inc. (NASDAQ:UG) Not Doing Enough For Some Investors As Its Shares Slump 29%
Nov 14These Return Metrics Don't Make United-Guardian (NASDAQ:UG) Look Too Strong
Nov 09Earnings Not Telling The Story For United-Guardian, Inc. (NASDAQ:UG) After Shares Rise 26%
Sep 08United-Guardian's (NASDAQ:UG) Upcoming Dividend Will Be Larger Than Last Year's
Jul 22Subdued Growth No Barrier To United-Guardian, Inc.'s (NASDAQ:UG) Price
Jul 15Recent updates
United-Guardian, Inc. (NASDAQ:UG) Not Doing Enough For Some Investors As Its Shares Slump 29%
Nov 14These Return Metrics Don't Make United-Guardian (NASDAQ:UG) Look Too Strong
Nov 09Earnings Not Telling The Story For United-Guardian, Inc. (NASDAQ:UG) After Shares Rise 26%
Sep 08United-Guardian's (NASDAQ:UG) Upcoming Dividend Will Be Larger Than Last Year's
Jul 22Subdued Growth No Barrier To United-Guardian, Inc.'s (NASDAQ:UG) Price
Jul 15United-Guardian (NASDAQ:UG) Has Some Difficulty Using Its Capital Effectively
May 14United-Guardian: Solid Balance Sheet, Solid Dividend, Strong Potential Upside
Feb 20Returns On Capital Signal Difficult Times Ahead For United-Guardian (NASDAQ:UG)
Feb 04United-Guardian, Inc.'s (NASDAQ:UG) Share Price Is Matching Sentiment Around Its Earnings
Dec 29Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)
Nov 07Estimating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)
Jul 18United-Guardian (NASDAQ:UG) Is Achieving High Returns On Its Capital
Mar 07Why We Like The Returns At United-Guardian (NASDAQ:UG)
Nov 11Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)
Oct 12Buying Back Into United-Guardian, Inc.
Aug 15United-Guardian (NASDAQ:UG) Will Pay A Smaller Dividend Than Last Year
May 15United-Guardian: Pristine Balance Sheet, Nice Dividend, But Fully Valued
Apr 11Estimating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)
Feb 01We Think Shareholders May Want To Consider A Review Of United-Guardian, Inc.'s (NASDAQ:UG) CEO Compensation Package
May 12Do Investors Have Good Reason To Be Wary Of United-Guardian, Inc.'s (NASDAQ:UG) 5.1% Dividend Yield?
Mar 15Should We Be Excited About The Trends Of Returns At United-Guardian (NASDAQ:UG)?
Feb 23Calculating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)
Feb 02United-Guardian's (NASDAQ:UG) Shareholders Are Down 11% On Their Investment Over The Past Five Years.
Jan 13Is The Market Rewarding United-Guardian, Inc. (NASDAQ:UG) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Dec 22Our View On United-Guardian's (NASDAQ:UG) CEO Pay
Dec 04United-Guardian cuts dividend by ~14%
Nov 20United-Guardian reports Q3 results
Nov 10Shareholder Returns
UG | US Personal Products | US Market | |
---|---|---|---|
7D | 2.1% | 4.3% | 2.2% |
1Y | 25.0% | -12.0% | 31.6% |
Return vs Industry: UG exceeded the US Personal Products industry which returned -11.6% over the past year.
Return vs Market: UG underperformed the US Market which returned 31.7% over the past year.
Price Volatility
UG volatility | |
---|---|
UG Average Weekly Movement | 8.7% |
Personal Products Industry Average Movement | 8.6% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: UG has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: UG's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1942 | 24 | n/a | www.u-g.com |
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company’s pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology.
United-Guardian, Inc. Fundamentals Summary
UG fundamental statistics | |
---|---|
Market cap | US$44.79m |
Earnings (TTM) | US$3.48m |
Revenue (TTM) | US$12.31m |
12.9x
P/E Ratio3.6x
P/S RatioIs UG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
UG income statement (TTM) | |
---|---|
Revenue | US$12.31m |
Cost of Revenue | US$5.73m |
Gross Profit | US$6.58m |
Other Expenses | US$3.09m |
Earnings | US$3.48m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.76 |
Gross Margin | 53.43% |
Net Profit Margin | 28.30% |
Debt/Equity Ratio | 0% |
How did UG perform over the long term?
See historical performance and comparison